NHS England and NHS Improvement Mandate Adoption of AI-powered HeartFlow Analysis to Fight Coronary Heart Disease
REDWOOD CITY, Calif.--(BUSINESS WIRE)--HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National Health Service England (NHSE) and NHS Improvement have mandated that English hospitals adopt the AI-powered HeartFlow FFRct Analysis to fight coronary heart disease (CHD), the leading cause of death in the UK. The HeartFlow Analysis has been selected as one of the innovations supported by NHSE’s new MedTech Funding Mandate. The Mandate, which will begin 01 A
